Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Get Smart: Leveraging New Technologies to Optimize Diabetes Management
  • CME
  • CE

Credits Available
Physicians: maximum of 1.0 AMA PRA Category 1 Credit
Registered Nurses: 1.0 Nursing contact hour
Pharmacists: 1.0 contact hour (0.1 CEUs)
Physician Assistants: maximum of 1.0 hour of AAPA Category I CME credit
Registered Dietitians/Dietetic Technicians, Registered: maximum of 1.0 CPEU(s)
Released: November 12, 2021 Expiration: November 11, 2022
Start Activity
Provided by Endocrine Society

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

In collaboration with Clinical Care Options
Supported by an educational grant from
Novo Nordisk Inc.
Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP
Anne Peters, MD
Jennifer Sherr, MD, PhD

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Analyze the benefits of diabetes technology with regard to reducing A1C, hypoglycemia, postprandial hyperglycemia, and improving time in range
  • Evaluate data obtained through diabetes technology to modify a diabetes pharmacotherapy plan
  • Describe steps to overcome barriers associated with diabetes technology

Information on this Educational Activity

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.

DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Faculty

Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP

Endocrine Clinical Pharmacy Specialist
CGM and Remote Monitoring Program Coordinator

Endocrinology and Metabolism Institute
Cleveland Clinic
Cleveland, Ohio

Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP, has disclosed that she has received consulting fees from Abbott, Dexcom, Insulet, Lilly, Medtronic, and Novo Nordisk.
Anne Peters, MD

Director, USC Clinical Diabetes Program
Professor of Clinical Medicine
Keck School of Medicine of USC
Los Angeles, California

Anne Peters, MD, has disclosed that she has received consulting fees from Abbott Diabetes Care, Biorad, Lilly, MannKind, Merck, Novo Nordisk, and Zealand; has received funds for research support from Abbott Diabetes Care and Dexcom; and has ownership interest in Omada Health and Teladoc.
Jennifer Sherr, MD, PhD

Associate Professor
Division of Pediatric Endocrinology
Department of Pediatrics
Yale School of Medicine
New Haven, Connecticut

Jennifer Sherr, MD, PhD, has disclosed that she has received consulting fees from Bigfoot Biomedical, Cecelia Health, Insulet Corporation, Lexicon, Medtronic Diabetes, Lilly, Sanofi, and Vertex; and has received funds for research support from Insulet Corporation, Medtronic Diabetes, and Lilly.

Staff

Kiran D. Mir-Hudgeons, PhD

Manager, Editorial Operations

Kiran Mir-Hudgeons, PhD, has no relevant conflicts of interest to report.
Ruth Cohen Cooper, CHCP

Vice President, Science and Strategy

Ruth Cohen Cooper, CHCP, has no relevant conflicts of interest to report.
Nicole Cunningham, MS, RD, CDE
Nicole Cunningham, MS, RD, CDE - no relevant conflicts of interest to report.
Julie Skowronski, FNP-BC
Julie Skowronski, FNP-BC, has no relevant conflicts of interest to report.
Jennifer Wohl, PA-C
Jennifer Wohl, PA-C, has no relevant conflicts of interest to report.
Taryn O'Loughlin Gross, PhD

Editorial Contributor

Taryn O’Loughlin Gross, PhD, has no relevant conflicts of interest to report.

The Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

Target Audience

This program is intended for the healthcare team involved in managing patients with diabetes including physicians, advance practice providers, physician assistants, and nurses who practice in an endocrinology, internal medicine, and family medicine setting as well as certified diabetes educators (dietitians and pharmacists).

Goal

The goal of this activity is to improve the knowledge and competence of learners on how current and emerging digital technology can better manage patients on insulin therapy by improving A1C/time in range, identifying hypoglycemia, and increasing adherence.

Physician Continuing Medical Education

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.

AMA PRA Category 1 Credit

The Endocrine Society designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

Accreditation

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by The Endocrine Society and Clinical Care Options, LLC (CCO). Clinical Care Options, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Nursing Continuing Education

Credit Designation

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.

Continuing Pharmacy Education

Credit Designation

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-21-231-H01-P.

Type of Activity: Application

Upon successfully completing the post-test with a score of 65% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Assistant Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. Approval is valid until November 11, 2022. PAs should only claim commensurate with the extent of their participation.

Registered Dieticians/Dietetic Technicians, Registered

Credit Designation

Registered Dietitians/Dietetic Technicians, Registered will receive 1.0 Continuing Professional Education unit (CPEUs) for completion of this activity.

Completion of this RD/DTR profession-specific or IPCE activity awards CPEUs (One IPCE credit = One CPEU). If the activity is dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (One 60 minute hour = 1 CPEU. RDs and DTRs are to select activity type 102 in their Activity Log. Performance Indicator selection is at the learner’s discretion.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from November 12, 2021, through November 11, 2022:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Get Smart: Leveraging New Technologies to Optimize Diabetes Management
  • CME
  • CE

Loading...
In this engaging video, hear guidance on current and emerging digital technology to help better manage patients on insulin therapy by improving A1C/time in range, identifying hypoglycemia, and increasing adherence.
Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP
Anne Peters, MD
Jennifer Sherr, MD, PhD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit
Registered Nurses: 1.0 Nursing contact hour
Pharmacists: 1.0 contact hour (0.1 CEUs)
Physician Assistants: maximum of 1.0 hour of AAPA Category I CME credit
Registered Dietitians/Dietetic Technicians, Registered: maximum of 1.0 CPEU(s)
Released: November 12, 2021 Expiration: November 11, 2022

Related Content

CCO slides: current and emerging digital technology to help better manage patients on insulin therapy.

Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP Anne Peters, MD Jennifer Sherr, MD, PhD Released: November 12, 2021

Diabetes technology health tools for patients and caregivers, provided by the Endocrine Society.

Released: November 9, 2021

Expert commentary on the use of diabetes technology according to new ADA/EASD consensus guidelines for type 1 diabetes, from Dr. Anne Peters and Clinical Care Options (CCO)

Anne Peters, MD Released: November 2, 2021

From Dr. Carol Hatch Wysham and Clinical Care Options (CCO), expert commentary on improving care for type 2 diabetes

Carol Hatch Wysham, MD Released: October 7, 2021
Provided by Endocrine Society

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

In collaboration with Clinical Care Options
Supported by an educational grant from
Novo Nordisk Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue